Sign in
Not yet recruitingPhase 1

Comparing Circadin and another melatonin product for primary insomnia

Compares Circadin with another melatonin product in people with primary insomnia.

Key facts

Who runs it
Pileje
Where
France1 site in 1 countryChoose a country to see its sites
Registry title
Etude de bioéquivalence entre Circadin et Melatonin PILEJE LP 2 mg
Status
Not yet recruiting
Phase
Phase 1
People taking part
24 people, planned
Started
31 Jul 2025
Planned end
31 Jan 2026
Type of study
Interventional
Record updated
28 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for men aged 18 to 64 years. It compares two melatonin medicines, Circadin and Melatonin PILEJE LP 2 mg, to see if the body takes them up the same way. Healthy volunteers can join.

Age
18 to 64 Years
Sex
Men only

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Comparing Circadin and another melatonin product for primary insomniaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from 2024-519932-17-00, who can take part
Record updated
28 August 2025